急性呼吸窘迫综合征体外膜氧合期间的机械通气管理:国际多中心前瞻性队列研究
该国际多中心前瞻性队列纳入23个国际ICU一年内因ARDS接受ECMO的350例患者(ECMO前PaO2/FiO2均值71±34 mm Hg),采集每日ECMO前后机械通气设置及6个月结局。ECMO启动后潮气量(6.4±2.0 vs 3.7±2.0 ml/kg)、平台压(32±7 vs 24±7 cm H2O)、驱动压(20±7 vs 14±4 cm H2O)、呼吸频率(26±8 vs 14±6次/分)和机械功率(26.1±12.7 vs 6.6±4.8 J/min)均明显降低,6个月生存率61%。多变量分析未发现ECMO前2天通气设置与生存相关;随时间变化的Cox模型显示年龄较大、液体平衡较高、乳酸较高及ECMO期间需肾脏替代治疗更多与6个月死亡独立相关,ECMO期间较高潮气量和较低驱动压(可能为静态顺应性改善的标志)与更好结局相关。作者结论认为ECMO期间机械通气设置在此背景下未影响预后。
要点
- ECMO启动后通气参数明显下降:潮气量6.4±2.0 vs 3.7±2.0 ml/kg、平台压32±7 vs 24±7 cm H2O、驱动压20±7 vs 14±4 cm H2O、呼吸频率26±8 vs 14±6次/分、机械功率26.1±12.7 vs 6.6±4.8 J/min。
- 6个月生存率61%;多变量分析未发现ECMO前2天通气设置与生存相关。
- 随时间变化Cox模型显示,年龄较大、液体平衡较高、乳酸较高、ECMO期间需肾脏替代治疗更多与6个月死亡独立相关。
- ECMO期间较高潮气量和较低驱动压(可能为静态顺应性改善的标志)与更好结局相关。
- ECMO前俯卧位通气使用率26%,神经肌肉阻滞剂使用率62%。
适用人群与场景
- 23个国际ICU中因重度ARDS接受ECMO治疗的患者,共350例,ECMO前PaO2/FiO2均值71±34 mm Hg。
研究设计与关键结果
- 研究类型为国际多中心前瞻性队列研究,纳入23个国际ICU一年内因ARDS接受ECMO的350例患者。
- ECMO启动后潮气量由6.4±2.0降至3.7±2.0 ml/kg,平台压由32±7降至24±7 cm H2O,驱动压由20±7降至14±4 cm H2O,呼吸频率由26±8降至14±6次/分,机械功率由26.1±12.7降至6.6±4.8 J/min。
- ECMO前俯卧位通气使用率26%,神经肌肉阻滞剂使用率62%。
- 6个月生存率为61%。
- 多变量分析未发现ECMO前2天通气设置与生存相关。
- 随时间变化的Cox模型显示,年龄较大、液体平衡较高、乳酸较高、ECMO期间需肾脏替代治疗更多与6个月死亡独立相关。
- ECMO期间较高潮气量和较低驱动压(可能为静态顺应性改善的标志)与更好结局相关。
证据类型、等级与局限
- 证据类型:国际多中心前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在此背景下ECMO期间机械通气设置未影响患者预后,与既往观察相反。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Current practices regarding mechanical ventilation in patients treated with extracorporeal membrane oxygenation (ECMO) for acute respiratory distress syndrome are unknown.Objectives: To report current practices regarding mechanical ventilation in patients treated with ECMO for severe acute respiratory distress syndrome (ARDS) and their association with 6-month outcomes.Methods: This was an international, multicenter, prospective cohort study of patients undergoing ECMO for ARDS during a 1-year period in 23 international ICUs.Measurements and Main Results: We collected demographics, daily pre- and per-ECMO mechanical ventilation settings and use of adjunctive therapies, ICU, and 6-month outcome data for 350 patients (mean ± SD pre-ECMO PaO2/FiO2 71 ± 34 mm Hg). Pre-ECMO use of prone positioning and neuromuscular blockers were 26% and 62%, respectively. Vt (6.4 ± 2.0 vs. 3.7 ± 2.0 ml/kg), plateau pressure (32 ± 7 vs. 24 ± 7 cm H2O), driving pressure (20 ± 7 vs. 14 ± 4 cm H2O), respiratory rate (26 ± 8 vs. 14 ± 6 breaths/min), and mechanical power (26.1 ± 12.7 vs. 6.6 ± 4.8 J/min) were markedly reduced after ECMO initiation. Six-month survival was 61%. No association was found between ventilator settings during the first 2 days of ECMO and survival in multivariable analysis. A time-varying Cox model retained older age, higher fluid balance, higher lactate, and more need for renal-replacement therapy along the ECMO course as being independently associated with 6-month mortality. A higher Vt and lower driving pressure (likely markers of static compliance improvement) across the ECMO course were also associated with better outcomes.Conclusions: Ultraprotective lung ventilation on ECMO was largely adopted across medium- to high-case volume ECMO centers. In contrast with previous observations, mechanical ventilation settings during ECMO did not impact patients' prognosis in this context.
参考来源
- Schmidt M, Pham T, Arcadipane A, et al. Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort. Am J Respir Crit Care Med. 2019. PMID: 31144997. doi:10.1164/rccm.201806-1094OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。